STAT+: The politics of passing a major FDA funding bill just got complicated

WASHINGTON — For the last six months, Congress seemed to be sailing towards the uncharacteristically smooth passage of a massive, multi-billion dollar bill to fund the Food and Drug Administration.

That all changed late last week when one powerful lawmaker, Sen. Richard Burr (R-N.C.), came out in opposition to the so-called user fee reauthorization bill he helped craft — and supported throughout the committee process.

Continue to STAT+ to read the full story…